We are pleased to announce a special research seminar celebrating Professor Trond G. Jenssen’s research contributions as he enters retirement. This event will showcase key moments and findings from his extensive research and collaborations throughout his distinguished career.

Chair:
Prof. Kåre I. Birkeland
Institute of Clinical Medicine, University of Oslo
Renal Section, Oslo University Hospital

Programme:

• 13.00 Head of Section Kristian Heldal, Renal section, Department of Transplantation Medicine, Oslo University Hospital: Welcome

• 13.10 Prof. Esteban Porrini, Laboratory of Renal Function (LFR), Faculty of Medicine, University of La Laguna, Tenerife, Spain: The metabolic syndrome and renal failure

• 13.40 Prof. Mads Hornum, Department of Nephrology and Endocrinology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark: Transplantation and diabetes - the Oslo-Copenhagen Connection

• 14.10 Prof. Bjørn Odvar Eriksen, Section of Nephrology, University Hospital of North Norway and Metabolic and Renal Research Group, UiT The Arctic University of Norway, Tromsø, Norway: Does high blood pressure accelerate ageing of our kidneys? – Results from the Renal Iohexol Clearance Survey (RENIS)

• BREAK

• 15.00 Prof. Anders Åsberg, Renal section, Department of Transplantation Medicine, Oslo University Hospital: Investigator-Initiated Clinical Trials at the Laboratory for Renal Physiology: Exploring Diabetes, Glucose Metabolism and Kidney Function

• 15.20 Prof. Hanne Scholz, Department of Transplantation Medicine, Oslo University Hospital, Hybrid Technology Hub Centre of Excellence, University of Oslo, Oslo, Norway: Islet cell transplantation – status and future

• 15.40 Senior physician Espen Nordheim, Renal section, Department of Transplantation Medicine, Oslo University Hospital: Pancreas transplantation in Norway

• 16.00 Senior physician Ingrid Charlotte Kongerud, Renal section, Department of Transplantation Medicine, Oslo University Hospital: The DEAK transplant study

• 16.20 Prof. Trond G. Jenssen – Concluding remarks

This seminar is open to all, and we warmly invite everyone to join us in celebrating Trond's remarkable achievements as he concludes his professional career and transitions into retirement.

Please feel free to share this announcement with anyone who may be interested. We look forward to seeing you there!

Join us for exciting Thursday Meeting. More details to follow!

Join us for exciting Thursday Meeting. More details to follow!

Agenda:

15.00–15.30 Welcome and Food Service

15.30–16.15 Heterogeneity and uncertainty in estimates of effect, by Lars Christian Stene

“Everybody” talks about heterogeneity, but there are so many different kinds of heterogeneity. “Everybody” talks about effects, but there are so many different measures of effect. I say most measures of effect have a lot of uncertainty, even in randomized trials. I will illustrate how scenarios with extreme variation in heterogeneity (and deterministic vs probabilistic scenarios) can give results that appear very similar, and how wide the 95% confidence intervals may be around measures of efficacy (effect) in real trials. Examples from the TN10 Teplizumab T1D prevention trial (K. Herold, NEJM 2019, approved for use in the USA, but points made are universal – I think).

16.15–16.30 Questions/Discussion

This is a hybrid event that allows for both in-person and online participation. A link has been distributed to everyone affiliated with Oslo Dibetes Research Center. If you haven’t receved an invite, please dont hesitate to contact us.

M.Sc. Chencheng Wang at Institute of Basic Medical Sciences will be defending the thesis “Human pluripotent stem cell-derived islet cells for diabetes modelling and drug testing” for the degree of PhD (Philosophiae Doctor).

Trial lecture: Chencheng Wang - Institute of Basic Medical Sciences (uio.no)

Public Defence: Chencheng Wang - Institute of Basic Medical Sciences (uio.no)

Venue: Stort møterom, Georg Sverdrups hus (University Library), UiO, Blindern, Oslo

08.30 WELCOME, Kåre I. Birkeland

TOPIC I: OMICS IN DIABETES RESEARCH Chair: Lars Christian Stene

08.45 Key note lecture I: MULTI-OMICS IN PRECICTION OF INCIDENT TYPE 2 DIABETES, Nick Wareham MRC, Cambridge, UK

09.30 Invited lecture: OMICS ANALYSES AT THE NORWEGIAN SEQUENCING CENTRE, Gregor Gifillan, OUS node at the Norwegian Sequencing Centre

10.00 ODF-presentation: CAN CHANGES IN INSULIN RESISTANCE AFTER EXERCISE TRAINING BE PREDICTED BY ARTIFICIAL INTELLIGENCE BASED ON LARGE-SCALE SERUM PROTEOMICS?, Sindre Lee-Ødegård

10.15    General discussion    

10.30    Coffee break

TOPIC II: TYPE 1 DIABETES AND COMPLICATIONS, Chair: Tore Julsrud Berg

11.00 Key note lecture II: LESSONS FROM THE LARGE NATIONWIDE FINNDIANE STUDY, Per-Henrik Groop, University of Helsinki, Finland

11.45 ODF-presentation: END-STAGE RENAL DISEASE: INCIDENCE AND PREDICTION BY CORONARY HEART DISEASE, AND EDUCATIONAL LEVEL. FOLLOW-UP FROM DIAGNOSIS OF CHILDHOOD-ONSET TYPE 1 DIABETES THROUGHOUT NORWAY 1973-2017, Maryam Saeed

12.00, ODF-presentation: INTESTINAL FATTY ACID BINDING PROTEIN IS ASSOCIATED WITH CORONARY ARTERY DISEASE IN LONG-TERM TYPE 1 DIABETES. THE DIALONG STUDY, Marte Narum

12.15 LUNCH 

TOPIC III: DIABETES AND EATING, Chair: Line Wisting

13.15 Key note lecture III: “I HAVEN’T TOLD ANYONE BUT YOU”: ASSESSING AND ADDRESSING BINGE EATING IN PEOPLE WITH TYPE 2 DIABETES, Pil Lindgreen, Steno Research Center, Copenhagen

14.00 ODF-presentation: DIABETES BODY PROJECT: SHORT-TERM EFFECTS OF AN EATING DISORDER PREVENTION PROGRAM FOR YOUNG FEMALES WITH TYPE 1 DIABETES, Severina Haugsvik

14.15 ODF-presentation: DIAMESTER, Anne Marie Aas

14.30 General discussion          

14.45 Coffee break      

TOPIC IV: PREVENTION OF TYPE 1 DIABETES, Chair: Lars Krogvold

15.00 Key note lecture IV: SCREENING AND PREVENTION OF TYPE 1 DIABETES, Helena Elding Larsson, CRC, Lund University, Malmö, Sweden

15.45 ODF-presentation: Long-term results of the DIVID-intervention study, Ida Maria Mynarek

16.00, ODF-presentations: PLANS FOR A NEW CLINICAL INTERVENTION STUDIES              

16.15 COMBINATION OF ANTIVIRAL AND IMMUNOMODULATION THERAPY FOR PREVENTION OF TYPE 1 DIABETES, Knut Dahl-Jørgensen

16.30 DECIDUAL STROMAL CELL THERAPY IN NEW-ONSET TYPE 1 DIABETES: A STRATEGY TO PROTECT AND PRESERVE CELLS, Hanne Scholz

16.45    General discussion          

17.00    COFFEE BREAK  

17.30    GENERAL ASSEMBLY      

18.30    DINNER OR TAPAS